Focal Segmental Glomerulosclerosis (FSGS) Unknown Status Phase 2 / 3 Trials for Valproic acid (DB00313)

Also known as: Focal Glomerulosclerosis / Glomerulosclerosis, Focal / Focal Segmental Glomerulosclerosis / Glomerulosclerosis, Focal Segmental / APOL1-mediated focal segmental glomerulosclerosis / Focal & segmental glomerulosclerosis / Focal glomerular sclerosis (disorder) / Focal segmental glomerulosclerosis (disorder)

IndicationStatusPhase
DBCOND0038485 (Focal Segmental Glomerulosclerosis (FSGS))Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02896270Valproic Acid for Idiopathic Nephrotic SyndromeTreatment